Maxcilin Duo Syrup (Amoxicillin·Clavulanate Potassium (7:1))
Amoxicillin Hydrate 36.326g · Dilute Potassium Clavulanate 10.352g
Syrup · Prescription medication · Combination
Albogene Korea Co., Ltd.
MFDS item code 201403890 · Notified 2014.08.20
This product's status changed to Approval withdrawn on 2025.03.31. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of respiratory and ear, nose, and throat infections, genitourinary infections, and skin, bone, and dental infections
This medication is used for various infections caused by different types of bacteria. It helps treat acute or chronic bronchitis, pneumonia, pulmonary abscess, and empyema. It is also effective against upper respiratory infections such as tonsillitis, sinusitis, and otitis media. Furthermore, it is used for urinary infections such as cystitis, urethritis, pyelonephritis, as well as pelvic infections and gonorrhea. It is widely used for treating abscesses, cellulitis, wound infections, osteomyelitis, and dental infections, aiding recovery from infections. Overall, it functions as an effective antibiotic for treating various infectious diseases.
Administer at the beginning of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin-clavulanic acid is optimized when administered at the beginning of a meal. <Preparation of this medicine> Add water to approximately 2/3 of the marked fill line and mix well. Then add water up to the fill line and shake thoroughly before use.
For mild to moderate infections such as upper respiratory tract infections, including recurrent tonsillitis, lower respiratory tract infections, urinary tract infections, and skin and soft tissue infections, the usual daily dose is 25 mg/3.6 mg per kg of body weight of amoxicillin/potassium clavulanate, divided into 2 doses. For severe infections such as upper respiratory tract infections, including otitis media and sinusitis, lower respiratory tract infections such as bronchopneumonia, and urinary tract infections, the usual daily dose is 45 mg/6.4 mg per kg of body weight of amoxicillin/potassium clavulanate, divided into 2 doses. The 7 : 1 syrup is not suitable for children under 2 months of age. The 7 : 1 syrup is not suitable for pediatric patients with renal impairment.
This medicine should not be used in patients with a history of hypersensitivity to penicillin or beta-lactam antibiotics. Caution is especially needed in cases with a history of severe allergic reactions such as anaphylaxis, Stevens-Johnson syndrome, or shock. It is advisable to avoid this medication in patients with infectious mononucleosis or lymphocytic leukemia due to an increased risk of rash. Patients with a history of liver dysfunction or jaundice should also use this medicine cautiously, as symptoms may recur. Patients with liver impairment should use it with caution due to the potential for worsened liver function. Moderately to severely impaired kidney patients may retain the drug in the body for a longer time, necessitating adjusted dosing intervals. Allergic individuals or those with asthma, rashes, or urticaria should use this medication cautiously. Patients who cannot take medicines orally, those receiving non-oral nutrition, elderly patients, or those in poor general condition may be at risk for bleeding due to vitamin K deficiency and should be observed. Patients with gastrointestinal symptoms such as vomiting or diarrhea may not absorb the medication adequately. Gastrointestinal side effects may include diarrhea, vomiting, abdominal pain, with the potential for serious colitis, such as pseudomembranous colitis, necessitating immediate cessation of use upon symptom occurrence. Liver function abnormalities may occur, particularly more frequently in elderly men; regular liver function tests are advised. Rarely, skin rashes, itching, or severe skin reactions may occur, and if these symptoms arise, immediate cessation of the medication and medical attention are required. Hematological abnormalities such as leukopenia, thrombocytopenia, and anemia may rarely occur, warranting caution. Central nervous system symptoms such as restlessness, anxiety, and seizures have been rarely reported, especially in patients with decreased renal function who are at risk of seizures, thus requiring attention. Impaired kidney function or acute renal failure may develop, necessitating regular renal function tests. This medication may affect the intestinal microbiota, potentially leading to disturbances such as candidiasis, requiring appropriate measures in case of symptom occurrence. Rarely, bleeding tendencies due to vitamin K deficiency or vitamin B complex deficiency symptoms may appear, warranting observation. Tooth discoloration may rarely occur; adherence to good oral hygiene can help prevent it. To prevent the emergence of antibiotic-resistant bacteria, it is essential to administer this drug for the minimum required duration following sensitivity testing. Severe allergic reactions may present, necessitating close observation of the patient post-administration; rapid and appropriate treatment should be provided in emergencies. Be aware of the potential for pseudomembranous colitis, and if diarrhea or abdominal cramping occurs, immediate cessation of use is required. With prolonged use, there is a risk of non-susceptible organism overgrowth; therefore, careful monitoring is necessary for treatment lasting longer than 14 days. Abnormalities in liver function tests have been reported, urging patients with liver dysfunction to be especially cautious, and it is preferable not to exceed 14 days of treatment. Dose adjustments are necessary for patients with moderately severe renal impairment. This medication should be avoided if infectious mononucleosis is suspected. If skin rashes, urticaria, or serum sickness symptoms appear, treatment should be promptly ceased and medical guidance should be followed. Regular monitoring of kidney, liver, and hematopoietic function is necessary with prolonged treatment. It is crucial to check for a history of penicillin or other allergies prior to use. Shake well before administration, store in the refrigerator after preparation, and use within 7 days. In the event of overdose, gastrointestinal symptoms and central nervous system symptoms may occur, requiring immediate cessation of the drug and appropriate treatment. Avoid administration during early pregnancy, and during pregnancy, it should only be used when the benefits outweigh the risks. Nursing mothers should discontinue use if adverse symptoms appear in the infant, as they may experience side effects. Exercise caution when using in premature infants and neonates, as safety has not been established. Elderly patients are at a higher risk of adverse reactions due to decreased physiological function; dosing and administration intervals should be adjusted. This medication may also affect the results of certain clinical tests, so care must be taken during testing. There may be interactions with other medications; inform your doctor or pharmacist of any medications you are taking.
Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, melena, dry mouth, acute pancreatitis, candidiasis, antibiotic-induced colitis, bloody stools, itching, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, blistering exfoliative dermatitis, acute generalized exanthematous pustulosis, eosinophilia, angioedema, anaphylaxis, serum sickness-like syndrome, hypersensitivity vasculitis, bronchospasm, dyspnea, laryngeal edema, anaphylactic shock, reversible leukopenia, thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphocytopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, vaginal itching, burning sensation, increased secretion, anxiety, restlessness, behavioral changes, confusion, drowsiness, insomnia, hyperactivity, dizziness, headache, seizures, antispasmodic, fever, altered consciousness, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, vitamin K deficiency symptoms, vitamin B complex deficiency symptoms, tooth discoloration, linear IgA disease, dysgeusia, malaise, dermatitis, oral edema, stomach pain, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, renal failure, interstitial encephalitis, hypersensitivity shock
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to prevent air and moisture from entering. The appropriate storage temperature is in a cool place between 1 and 25 degrees.
A whitish powder with a unique smell used in reconstituted syrup form
50mL/bottle x 1
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amoxicillin Hydrate 36.326g · Dilute Potassium Clavulanate 10.352g
Syrup · Prescription medication · Combination
Albogene Korea Co., Ltd.
CombinationAmoxicillin Hydrate 500mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
Geonil Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 125mg · Dilute Potassium Clavulanate 107.76mg
Tablet · Prescription medication · Combination
Geonil Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
HLB Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 500mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
HLB Pharmaceuticals Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 215.52mg
Tablet · Prescription medication · Combination
Dong Sung Pharmaceutical Co., Ltd.
CombinationAmoxicillin Hydrate 250mg · Dilute Potassium Clavulanate 212.73mg
Tablet · Prescription medication · Combination
Youngjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.